Neptune Wellness Solutions (NASDAQ:NEPT) Stock Rating Lowered by BidaskClub

BidaskClub downgraded shares of Neptune Wellness Solutions (NASDAQ:NEPT) (TSE:NTB) from a sell rating to a strong sell rating in a research note issued to investors on Saturday, March 23rd, BidAskClub reports.

A number of other research analysts have also issued reports on NEPT. Echelon Wealth Partners reiterated a buy rating on shares of Neptune Wellness Solutions in a report on Wednesday, January 9th. Zacks Investment Research upgraded Neptune Wellness Solutions from a hold rating to a buy rating and set a $3.75 target price for the company in a report on Wednesday, March 13th. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The stock currently has a consensus rating of Hold and an average price target of $3.75.

NASDAQ:NEPT traded up $0.09 during midday trading on Friday, reaching $3.65. The company had a trading volume of 466,803 shares, compared to its average volume of 640,646. The firm has a market cap of $293.45 million, a PE ratio of 21.47 and a beta of 1.84. Neptune Wellness Solutions has a 12-month low of $2.31 and a 12-month high of $5.14.

Neptune Wellness Solutions (NASDAQ:NEPT) (TSE:NTB) last released its earnings results on Wednesday, February 13th. The biotechnology company reported ($0.04) earnings per share (EPS) for the quarter. The company had revenue of $4.95 million during the quarter. Neptune Wellness Solutions had a negative net margin of 60.48% and a negative return on equity of 18.85%. Equities analysts anticipate that Neptune Wellness Solutions will post -0.06 earnings per share for the current fiscal year.

A number of institutional investors have recently bought and sold shares of NEPT. Wells Fargo & Company MN raised its stake in Neptune Wellness Solutions by 236,363.6% in the third quarter. Wells Fargo & Company MN now owns 26,011 shares of the biotechnology company’s stock valued at $101,000 after buying an additional 26,000 shares in the last quarter. Virtu Financial LLC raised its stake in Neptune Wellness Solutions by 493.7% in the third quarter. Virtu Financial LLC now owns 165,322 shares of the biotechnology company’s stock valued at $733,000 after buying an additional 137,478 shares in the last quarter. Renaissance Technologies LLC raised its stake in Neptune Wellness Solutions by 696.0% in the third quarter. Renaissance Technologies LLC now owns 93,654 shares of the biotechnology company’s stock valued at $363,000 after buying an additional 81,889 shares in the last quarter. Perceptive Advisors LLC raised its stake in Neptune Wellness Solutions by 3.7% in the third quarter. Perceptive Advisors LLC now owns 8,891,452 shares of the biotechnology company’s stock valued at $34,498,000 after buying an additional 317,437 shares in the last quarter. Finally, Fisher Asset Management LLC acquired a new stake in Neptune Wellness Solutions in the fourth quarter valued at $51,000. Institutional investors own 14.67% of the company’s stock.

About Neptune Wellness Solutions

Neptune Wellness Solutions Inc, a health and wellness products company, engages in the extraction, purification, and formulation of value-added differentiated science based products. It develops turnkey nutrition product solutions in various delivery forms. The company offers specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.

Recommended Story: Leveraged Buyout (LBO)

Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.